NOW, HOPE FOR SOME PARALYZED PATIENTS.
CLINICAL TRIALS WILL START NEXT MONTH USING CELL REPLACEMENT THERAPY TO REPAIR SPINAL CORD DAMAGE.
IT'S THE ONLY TRIAL OF IT'S KIND IN THE WORLD AND A MAJOR STEP TOWARDS FINDING A *CURE* FOR PARALYSIS.
"Every great journey starts with a first step we're here today to celebrate that first step."
"The FDA has approved the Miami Project to conduct a human clinical trial for Schwann Cell Transplantation in individuals with spinal cord injury."
FOR THE STUDY. A PIECE OF A PERIPHERAL NERVE WHICH HAS SCHWANN CELLS WILL BE TAKEN FROM THE PATIENT AND USED TO GENERATE MILLIONS OF THESE CELLS. THREE TO FIVE WEEKS LATER THEY WILL BE INJECTED INTO THE INJURED AREA OF THE SPINAL CORD.
"And then they mylenate they re-insulate the damaged fibers, the schwann cells also make the injured spinal cord more permissive for regeneration."
"These are not stem cells but the fact that we can use a person's own cells is extremely important."
IN THIS PHASE ONE STUDY RESEARCHERS WILL ONLY BE TESTING SAFETY IN 8 NEWLY INJURED PATIENTS. THE CELLS MUST BE TRANSPLANTED 26 TO 40 DAYS AFTER INJURY
THE ANNOUNCEMENT WAS MADE IN A ROOMFUL OF SCIENTISTS, SUPPORTERS AND PATIENTS WITH RENEWED HOPE.
"This is what I still go to physical therapy once a week for and I try to stay as active as possible for this day so it's very emotional and exciting."
THE POTENTIAL FOR THIS THERAPY, GOES BEYOND SPINAL CORD INJURY
"But there are tens of millions of people out there who have brain injuries and other neurological degenerative diseases and all of these people potentially can benefit from this ability to repair the central nervous system."
"I've been here 29 years i want to get up already. I have a lot of dancing to do."
IF THIS STUDY SHOWS THE CELL THERAPY IS SAFE IN THE NEWLY INJURED... RESEARCHERS PLAN TO IMMEDIATELY APPLY FOR F-D-A APPROVAL TO BEGIN TRYING IT IN PEOPLE WHO'VE BEEN IN CHAIRS FOR YEARS.
A recall for epipen devices has expanded in the US and…
Dentistry from the Heart gets underway at 7:30 Friday morning.
Banner Health in Phoenix is starting the first phase of a clinical…